Diane V. Havlir
Division of Infectious Diseases
University of California
150 West Washington Street
Suite 100
USA
Name/email consistency: high
- Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?. Havlir, D.V. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Prevalence and predictive value of intermittent viremia with combination hiv therapy. Havlir, D.V., Bassett, R., Levitan, D., Gilbert, P., Tebas, P., Collier, A.C., Hirsch, M.S., Ignacio, C., Condra, J., Günthard, H.F., Richman, D.D., Wong, J.K. JAMA (2001)
- Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. Havlir, D.V., Hellmann, N.S., Petropoulos, C.J., Whitcomb, J.M., Collier, A.C., Hirsch, M.S., Tebas, P., Sommadossi, J.P., Richman, D.D. JAMA (2000)
- In vivo antagonism with zidovudine plus stavudine combination therapy. Havlir, D.V., Tierney, C., Friedland, G.H., Pollard, R.B., Smeaton, L., Sommadossi, J.P., Fox, L., Kessler, H., Fife, K.H., Richman, D.D. J. Infect. Dis. (2000)
- Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. Havlir, D.V., Schrier, R.D., Torriani, F.J., Chervenak, K., Hwang, J.Y., Boom, W.H. J. Infect. Dis. (2000)
- Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. California Collaborative Treatment Group. Havlir, D.V., Haubrich, R., Hwang, J., Dunne, M.W., Currier, J., Forthal, D., Torriani, F., Richman, D.D., McCutchan, J.A. J. Infect. Dis. (1998)
- Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. Havlir, D.V., Eastman, S., Gamst, A., Richman, D.D. J. Virol. (1996)